Abstract Submission

1. Uluslararasi Hematoloji-Onkoloji Dergisi (UHOD) (International Journal of Hematology and Oncology) is a peer-reviewed and official journal of Akademi Doktorlar Yayinevi (Publisher) and publishes research articles, reviews, invited reviews, scientific meeting abstracts and letters to the editor in all aspects of both clinical and experimental Hematology, Oncology and Radiation Oncology.

2. UHOD is published every three months (one volume per annum). The Conference Abstracts will be published as an independent Supplement comprised of scientific meeting abstracts in cooperation with the Kan ve Kemik İliği Nakli Derneği, Ankara-Turkey.

3. The abbreviation of the journal for citing is “UHOD”.

4. It is the authority of Editorial Board and Congress President to accept, reject or transmit the submitted manuscripts to Advisory Board for further review.

5. It is the author(s)’ responsibility that the submitted Abstract is original work, not previously published elsewhere.

6. In the materials section of the research where experimental studies on humans are presented, a statement that informed consent were taken from the volunteers or patients after the explanation of the procedures should be included. This section also should contain a statement that the investigation confirms the principles outlined in Helsinki Declaration (available at www.ub.edu). For experimental studies on animals, research protocol should be in accordance with international agreements (Guide for the care and use of laboratory animals - www.grants.nih.gov). A copy of approval from ethics committee should be sent.

7. Abstracts should be written in English.

8. Manuscripts should be sent by Online Submission system of Kan ve Kemik İliği Nakli Derneği, Ankara-Turkey. Papers should be typed in 12 point typescript and double-spaced throughout the text including tables.

9. Abstract Research should not exceed 400 words and include: shortened form of Introduction, Materials (Patients) and Methods, Results, and Discussion.
The abstract should be in English with an appropriate title, and should not exceed 400 words. It should start with a sentence indicating the rationale of the study and summarize the results and conclusions concisely.

10. Abstracts of case reports and other subjects of particular interest are reviewed by the Editorial Board and Congress President. They should be concise and limited to 400 words with one Patient Picture if available and/or table.

11. Abbreviations should be standard. Any nonstandard abbreviations should be defined in the text when first used.

12. All illustrations, art works and figures should be original. It is the authors’ responsibility to obtain necessary permissions for any material with copyright. Illustrations, figures and graphics should be prepared in tiff format with a minimum resolution of 300 dpi. They should be clear, sharp, easily readable and legible. Illustrations must be cited in consecutive numerical order in the text. The staining method and the magnification rate should be indicated in microscopic illustrations (e.g. H&E, x400). Submitted photographs, figures and graphics should be of professional quality. Legends for the figures should be typed double-spaced on a separate page. They must be concise and represent summaries of findings. Authors should retain one copy of original art work.